Amphetamine Stimulant Prodrug denied as non-formulary by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for amphetamine stimulant prodrug are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Lists This Drug as Non-Formulary

UnitedHealthcare's drug formulary — the list of covered medications — is tiered and updated periodically by UHC's Pharmacy and Therapeutics committee. Amphetamine-based stimulant prodrugs may be placed on a non-preferred or non-formulary tier when the committee determines that therapeutically similar alternatives are available at lower cost to the plan. A non-formulary denial does not mean the drug is medically inappropriate; it means UHC wants evidence that formulary alternatives are not suitable for this specific patient before it will cover the requested drug.

## Why This Denial Is Appealable

All formulary tiers allow for a medical exception (formulary exception) process. If the prescriber can document that formulary alternatives are contraindicated, have been tried and failed, or are clinically inferior for a specific, documented patient reason, UHC is required under its own exception process — and under ACA §2719 / ERISA §503 — to consider coverage of the non-formulary drug. The exception pathway exists precisely for situations like this.

## Federal Appeal Framework

• Formulary exception request: This is often a separate, faster pathway than the standard appeal — UHC must respond within set timeframes. Pursue this in parallel with or before the formal internal appeal.
• Internal appeal (ACA §2719 / ERISA §503): If the exception is denied, a formal internal appeal follows. Submit within the deadline on the denial notice.
• External review: After exhausting internal appeals, you have approximately four months from the final internal denial to request independent external review. Expedited review is available for urgent situations.

## Concrete Appeal Steps and Timeline

1. Obtain UHC's current formulary and identify which tier alternatives UHC prefers for this class. 2. Request UHC's formulary exception criteria — the specific clinical requirements for a non-formulary drug to be approved. 3. Document the patient's experience with each formulary alternative — tried and failed, contraindicated, or clinically not equivalent with prescriber rationale. 4. Submit the formulary exception and/or internal appeal with a prescriber letter addressing each UHC exception criterion. 5. Escalate to external review if the exception and internal appeal are both denied.

## Documentation to Gather

• Formulary alternative trial history: Each alternative tried, dates, documented outcomes or adverse effects, and reason for discontinuation — with chart support.
• Prescriber medical-necessity letter: Should explicitly address UHC's exception criteria and explain why non-formulary medication is necessary for this patient.
• Diagnosis documentation: Chart notes establishing the condition, its severity, and clinical context.
• Clinical notes on tolerability or clinical distinction: Any specific patient characteristic (documented in the chart) that makes the requested drug clinically preferable over the formulary alternative.

## Criteria-Mapping Structure

| UHC Formulary Exception Criterion | Patient Evidence | |---|---| | Each formulary alternative UHC requires to be tried | Document trial date, outcome, and prescriber rationale for inadequacy | | Any additional exception criteria in UHC's policy | Cite chart note and prescriber letter statement for each |

The formulary exception pathway at UHC can move quickly when the prescriber's letter directly mirrors the exception criteria language. Use UHC's own criteria as the structure for the submission.